Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...

Interest in weight-loss medications is at an all-time high, with promising study results and inspiring success stories coming ...

The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

Anecdotal reports suggest drugs like Ozempic may curb not just appetite but also impulsive or addictive behaviour, hinting at ...

He is treating his fluid retention with 100 mg of furosemide daily. He also has mild, untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned ...

He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid retention with 100 mg of furosemide daily. He also has mild, untreated sleep apnea. He would like to try one of the GLP-1 ...

They were then randomly assigned to one of four treatment groups for an additional four weeks: co-administration of MC4R bremelanotide (1.25 mg daily) and GLP-1/GIP tirzepatide (2.5 mg weekly ...

He is five-foot-seven and 270 pounds. He takes 100 mg of furosemide daily. He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned ...

They were then randomly assigned to one of four treatment groups for an additional four weeks: co-administration of MC4R bremelanotide (1.25 mg daily) and GLP-1/GIP tirzepatide (2.5 mg weekly), ...

GLP-1 (glucagon-like peptide-1 ... had a 14.9% mean weight loss on the 2.4 mg weekly injection after 68 weeks during its Phase 3 STEP 1 study. Zepbound (Eli Lilly) had a 20.9% mean weight loss ...